Matching slides 303,780
Current window 39,511-39,540
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

39,511-39,540 of 303,780

filter-aware
92
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
94
The slide uses a car illustration to represent the telematics context.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
95
The slide uses a visual risk gauge to indicate that the profile falls into the top 10% highest risk category.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
97
The slide uses a screenshot-based approach to illustrate a digital product workflow.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
99
The slide uses a screenshot of a software interface to demonstrate AI-driven telematics capabilities.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
100
The slide shows two map-based visualizations of location tracking or geofencing.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
101
The slide uses a cyclical process flow to describe the continuous improvement loop of insurance product pricing.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 2 hits
114
The chart uses annotations to show resilience against macroeconomic events like COVID, inflation, and geopolitical instability.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action2 hits
117
The chart uses a trend line to illustrate the trajectory toward profitability.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action2 hits
118
The chart tracks performance from Q1-20 to Q4E-22, highlighting IPO, Pet, Car, and MILE milestones.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action2 hits
119
The chart uses a simple two-bar comparison to highlight efficiency gains.Lemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action2 hits
120
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action2 hits
01
Slide 1
Matson | Investor Presentation Deck | 15 slidesMatson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations 2 hits
10
The chart shows a significant increase in equity income for LTM 3Q22.Matson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations Beat · Financials2 hits
12
Matson | Investor Presentation Deck | 15 slidesMatson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations 2 hits
04
Matson | Results Presentation Deck | 20 slidesMatson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
07
The chart compares quarterly container volumes between 2021 and 2022, specifically noting the impact of service changes on Q3 volume.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 2 hits
08
The chart shows quarterly container volume (FEU) for 2021 and 2022, highlighting a 1.8% YoY decrease in Q3.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 2 hits
09
The chart compares quarterly container volumes (FEU) between 2021 and 2022, with a specific callout for the 10.6% growth in Q3.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 2 hits
13
The chart shows a starting cash flow of $1,503.3M and a final net increase in cash of $165.5M after various outflows.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Pareto Focus2 hits
03
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits
10
Uses a temple pillar metaphor to represent the evolution of cancer treatment options.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Problem Statement2 hits
28
The data shows a clear trend where the combination of iNKT activator + Fc enhanced CTLA-4 + PD-1 (Group F) results in the lowest number of metastases.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After2 hits
37
Includes abstract number 372.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Key Takeaways2 hits
40
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Key Takeaways2 hits
42
The diagram illustrates the interaction between iNKT cells and tumor cells/immune cells via various receptors (CAR, iTCR, NKG2D, DNAM1).Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits
46
The slide uses a bar chart to show the distribution of clones, with a red circle highlighting the 'binders specific activators' category.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits
55
The slide illustrates the CARDIS platform workflow and the resulting distribution of binders vs non-binders.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits
56
The slide uses a biological process diagram to explain the therapeutic mechanism of iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits
57
The slide highlights the scalability of the manufacturing process by showing the enrichment of iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 2 hits